Efficacy and risk profile of anti-diabetic therapies: Conventional vs traditional drugs-A mechanistic revisit to understand their mode of action.

Gupta, Prachi; Bala, Manju; Gupta, Sanjeev; Dua, Anita; Dabur, Rajesh; Injeti, Elisha; Mittal, Ashwani

Gupta, Prachi; Bala, Manju; Gupta, Sanjeev; Dua, Anita; Dabur, Rajesh; Injeti, Elisha; Mittal, Ashwani.

Afiliación

Gupta P; Skeletal Muscle Lab, University College, Kurukshetra University, Kurukshetra, Haryana, 136119, India.
Bala M; Skeletal Muscle Lab, University College, Kurukshetra University, Kurukshetra, Haryana, 136119, India.
Gupta S; Skeletal Muscle Lab, University College, Kurukshetra University, Kurukshetra, Haryana, 136119, India.
Dua A; Skeletal Muscle Lab, University College, Kurukshetra University, Kurukshetra, Haryana, 136119, India.
Dabur R; Biochemistry Department, Maharshi Dayanand University, Rohtak, Haryana, 124001, India.
Injeti E; Department of Pharmaceutical Sciences, Cedarville University, Cedarville, OH, 45314, USA.
Mittal A; Skeletal Muscle Lab, University College, Kurukshetra University, Kurukshetra, Haryana, 136119, India. Electronic address: mittala@kuk.ac.in.

Pharmacol Res ; 113(Pt A): 636-674, 2016 11.

Article en En | MEDLINE | ID: mdl-27697646

Asunto(s)

Diabetes Mellitus Tipo 2/tratamiento farmacológico; Hipoglucemiantes/farmacología; Hipoglucemiantes/uso terapéutico; Animales; Manejo de la Enfermedad; Humanos; Hipoglucemiantes/efectos adversos; Riesgo; Transducción de Señal/efectos de los fármacos

Palabras clave

Acarbose (PubChem CID: 41774); Alogliptin (PubChem CID: 11450633); Anti-diabetic drugs; Canagliflozin (PubChem CID: 24812758); Dapagliflozin (PubChem CID: 9887712); Dipeptidyl peptidase-4 inhibitors; Exenatide (PubChem CID: 56927919); Gliclazide (PubChem CID: 3475); Glimepiride (PubChem CID: 3476); Glyburide (PubChem CID: 3488); Linagliptin (PubChem CID: 10096344); Liraglutide (PubChem CID: 16134956); Lixisenatide (PubChem CID: 90472060); Metformin; Metformin (PubChem CID: 4091); Miglitol (PubChem CID: 441314); Nateglinide (PubChem CID: 5311309); Phlorizin (PubChem CID: 6072); Phyto-drugs; Pioglitazone (PubChem CID: 4829); Pramlintide (PubChem CID: 16132446); Repaglinide (PubChem CID: 65981); Resveratrol (PubChem CID: 91745415); Rosiglitazone (PubChem CID: 77999); SGLT2; Saxagliptin (PubChem CID: 11243969); Sitagliptin (PubChem CID: 4369359); Sulfonylureas; Taspoglutide (PubChem CID: 56842233); Teneligliptin (PubChem CID: 11949652); Thiazolidinediones; Tolbutamide (PubChem CID: 5505); Type 2 diabetes mellitus; Vildagliptin (PubChem CID: 6918537); Voglibose (PubChem CID: 444020); miRNAs

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Hipoglucemiantes Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Año: 2016 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google